Research Affiliates
Sponsored Research
From time to time, the Myelin Repair Foundation research plan requires scientific expertise outside the core team of Principal Investigators. The following institutions are currently conducting sponsored research projects to advance the Myelin Repair Foundation’s mission to bring myelin repair therapies to multiple sclerosis patients as rapidly as possible. At this time, the Myelin Repair Foundation does not consider unsolicited proposals for sponsored research.
- Center for Stem Cell and Regenerative Medicine
- Wensheng Lin, M.D., Ph.D.
Assistant Professor, Cell Biology and Neuroscience
University of South Alabama
- Back to top -
Contract Research Organizations
To advance the most promising drug targets toward commercial development, the Myelin Repair Foundation partners with contract research organizations (CROs) for critical validation and drug discovery studies. The following CROs have or are currently working with the Myelin Repair Foundation on these studies.
- Blue Dolphin Lead Discovery LLC
- Bolder Biopath, Inc.
- Charles River Laboratories, Pathology Associates, Inc.
- Collaborative Drug Discovery
- Dalton Pharma Services
- Datacloud SPLTrak
- Mayo Clinic Chemical Synthesis Core Facility
- Neuroscience Associates
- Pharmoptima
- PPD
- Tox Path Specialists, LLC
- Back to top -
Take Action
Stay Up To Date on MRF’s News and Research
Sign up to receive our FREE newsletter, MyelinConnection, via email every month.
Make a Donation
Your gift today will help us reach the first myelin repair Phase I Clinical Trial by 2014.
